This phase II/III trial is looking at different treatment protocols for children and adolescents with Langerhans Cell Histiocytosis.
This trial is treating patients with Langerhans Cell Histiocytosis.
This is a systemic therapy trial.
You may be excluded from this trial if:
- You have a certain disease or psychological condition.
- You have had certain treatments, surgical procedures or drugs.
Clinical trials have complex eligibility criteria - talk to your doctor about your interest in this trial.
Clinical Summary Read More
Use the hyperlinks, where available to access additional clinical trial information.
International Collaborative Treatment Protocol for Children and Adolescents With Langerhans Cell Histiocytosis
Other Non-Commercial Sponsor
Dana-Farber Cancer Institute
The LCH-IV is an international, multicenter, prospective clinical study for pediatric Langerhans Cell Histiocytosis LCH (age < 18="">
Recruiting Hospitals Read More